Cancer ‘drug’ put patients at risk

The creator of a controversial ‘wonder drug’ made from human blood will stand trial for risking patient safety to pocket millions from the sale of outlawed medicines. David Noakes, 64, is the CEO and beneficial owner of Immuno Biotech Ltd. He is said to have used the firm to actively promote products containing GcMAF, made using human blood, by holding it out as a cure for a number of illnesses and conditions including cancer, multiple sclerosis, HIV and autism. But…